Minolexin® in complex therapy of papulo-pustular acne of moderate severity (results of own research)

Author:

Khismatulina I. M.1ORCID

Affiliation:

1. Kazan State Medical University

Abstract

The aim of the study. A retrospective analysis of the results of complex therapy of moderate papulo-pustular acne with minocycline 50 mg per day orally and 15 % azelaic acid gel topically under natural ultraviolet irradiation.Materials and methods. In a retrospective study, data from outpatient charts and the results of studying the morpho-functional parameters of the facial skin of 61 people (31 acne patients and 30 healthy individuals) were analyzed. Patients received oral minocycline (Minolexin®) 50 mg per day for 6 weeks and topically 15 % azelaic acid gel 2 times a day for 12 weeks in the period from April to September.Results and discussion. The therapy was effective: clinical cure occurred in 90.3 % (n = 28), clinical remission – in 9.7 % (n = 3) patients. Rapid regression of papulo-pustules was achieved through the use of minocycline, which had antibacterial and anti-inflammatory effects. After treatment, elevated values of sebumetry, skin relief, pore size, and pigmentation were normalized in the group of patients with acne, due to the action of a topical gel, as well as the absence of photosensitizing effect in minocycline. Systemic and local adverse events registered in outpatient records were of a temporary nature and did not require discontinuation of therapy.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference6 articles.

1. Federal clinical guidelines. Dermatovenerology, 2020. Acne Vulgaris (L70). Russian Society of Dermatovenerologists and Cosmetologists. (In Russian). https://www.cnikvi.ru/docs/clinic_recs/klinicheskie-rekomendatsii-2019-2020/files/КР%20Акне%202020.docx

2. Ju et al. Chinese Guidelines for the Management of Acne Vulgaris: 2019 Update. International Journal of Dermatology and Venereology. 2019. V. 2. No. 3. P. 129–138. DOI: 10.1097/JD9.0000000000000043.

3. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016. V. 74. No. 5. P. 945–973. DOI: 10.1016/j.jaad.2015.12.037.

4. Nast A., Dréno B., Bettoli V., Bukvic Mokos Z., et al. European evidence-based (S3) guideline for the treatment of acne – ​update 2016 – ​short version. Journal of the European Academy of Dermatology and Venerology. 2016. V. 30. No. 8. P. 1261–1268. DOI: 10.1111/jdv.13776.

5. Instructions for the use of the medicinal product for medical use Minolexin®. Reg. No. LP-(000754)-(RG-RU) from 04.05.22 (In Russian)] https://www.vidal.ru/drugs/molecule-in/1199

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3